Urinary tract infection is termed as bladder infection that can be defined as the infection in urinary tube caused by the gram negative bacteria. If left untreated, it can spread to kidneys and bladder. The urinary tract infection is more prevalent in women compared with men due to the fact that the urethra is shorter for women than men which allows bacteria quick access to the bladder. Thus, germs can easily move from urethra to the bladder and cause an infection. The symptoms of urinary tract infection includes burning sensation during urination, pain in the lower belly and the color of the urine is red or pink. Risk factors for urinary tract infection includes suffering from diabetes, pregnancy, kidney stone and prostate cancer. Urinary tract infections are more concerning in pregnancy due to the increased risk of kidney infections.
Urinary Tract infections Market: Drivers and Restraints
With rising prevalence of diabetes, prostate cancer, the global market for urinary tract infection treatment would also increase. Moreover, technological advancements such as introduction of CT scan and ultrasound for the diagnosis of urinary tract infections also accentuates the global urinary tract infections treatment market. However, lack of awareness among people might hinder the global market.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1340
Urinary Tract infections Market: Segmentation
Urinary tract infections market is segmented on the basis of drug type, distribution channel and geography.
Based on drug type, urinary tract infections market is segmented as follows:
• Trimethoprim/sulfamethoxazole
• Fosfomycin
• Nitrofurantoin
• Ciprofloxacin
• Levofloxacin
• Cephalexin
• Ceftriaxone
• Azithromycin
• Doxycycline
Based on distribution channel, urinary tract infections market is segmented as follows:
• Hospitals including hospital pharmacies
• Retail pharmacies
• Clinics
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1340
Urinary Tract infections Market: Overview
Unhygienic environment is majorly responsible for urinary tract infections market especially for women. Urinary Tract Infections (UTI) are one of the most common infectious diseases diagnosed in outpatients as well as in hospitalized patients. The diagnosis of this infection includes urinalysis or urine culture, ultrasound or CT scan of the urinary tract. Aging population is also responsible for the growth of urinary tract infections market. This is also a reason for increase in the demand for urinalysis tests. Using urinary catheters as little and as short of time as possible and appropriate care of the catheter when used prevents infections.
Urinary Tract infections Market: Region-wise Outlook
Region wise, the global urinary tract infections market is classified into countries namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the global market for urinary tract infection due to increasing awareness among people about the infection and is followed by Europe. For an instance, in 2013, American Urological Association (AUA) stated that every year around 8.1 million of the U.S. population is diagnosed with urinary tract infection that comprises 40% women and 20% men. Asia-pacific and others are considered as untapped markets due to the lack of awareness among people for urinary tract infection.
Full Report Analysis@ http://www.futuremarketinsights.com/reports/urinary-tract-infections-market
Urinary Tract infections Market: Key Players
Major market players contributing to the global market share of urinary tract infections drugs market includes GlaxoSmithKline, Pfizer, Abbott, Merck and Co., Cipla Laboratories, Novartis AG, Bristol Meyer Squibb and Reddys Lab.